Совместимость Алфупрост® МР и Ситара
Страница описания препарата Алфупрост® МР
Страница описания препарата Ситара
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects
J Clin Pharmacol /Volume:47 Part:10/Oct Page:1303-10 / 2007 / Guillaume M, Lonsdale F, Darstein C et al
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men
J Urol /Volume:172 Part:5 Pt 1/Nov Page:1935-40 / 2004 / Kloner RA, Jackson G, Emmick JT et al
Therapy of ED: PDE-5 inhibitors
Endocrine /Volume:23 Part:2-3/Mar-Apr Page:135-41 / 2004 / Shabsigh R
Novel phosphodiesterase type 5 inhibitors: assessing hemodynamic effects and safety parameters
Clinical Cardiology /Volume:27 Part:4 Supp 1/Apr Page:I20-5 / 2004 / Kloner RA